ProfileGDS5678 / 1419611_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 63% 64% 63% 63% 69% 65% 63% 64% 64% 64% 64% 64% 64% 64% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.829563
GSM967853U87-EV human glioblastoma xenograft - Control 23.8041864
GSM967854U87-EV human glioblastoma xenograft - Control 33.737663
GSM967855U87-EV human glioblastoma xenograft - Control 43.7383163
GSM967856U87-EV human glioblastoma xenograft - Control 54.2807569
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.956765
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.833163
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.8128164
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.8051764
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.8563864
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.8206664
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.8217564
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.8258664
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.8242564